Loading
Paul Biondi

Paul Biondi, MBA

General Partner; President
Flagship Pioneering; Pioneering Medicines
Paul is a General Partner at Flagship Pioneering and President of Pioneering Medicines, Flagship’s in-house drug discovery and development unit. Pioneering Medicines also partners with external collaborators across biopharma throughout the R&D process, applying its unique approach to the R&D priorities of partners through highly co-creative relationships. Current partners include the Cystic Fibrosis Foundation, Novo Nordisk, and Pfizer. In his role at Flagship, Paul also works with growth company CEOs and their teams to achieve the best attainable value for each company. He serves on the boards of Flagship-founded companies, including Seres Therapeutics and Valo Health. Paul joined Flagship Pioneering following a seventeen-year tenure at Bristol-Myers Squibb (BMS). He served as the SVP of Strategy and BD, where he had enterprise-wide responsibility for establishing and evolving BMS’s strategy and for pursuing strategic transactions to access external innovation, enhance BMS’s capabilities, and strengthen its portfolio. Prior to this role, Paul held a series of leadership roles within BMS’ R&D organization, overseeing strategy, portfolio and project management, and clinical and business operations. Paul previously spent nine years at Mercer Management Consulting. Paul received his M.B.A. from the J.L. Kellogg School of Management at Northwestern University and his B.A. from Dartmouth College.
Speaking In

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS